Pivot Bio has closed its $100 million Series C funding round co-led by return investors. Pivot Bio will deploy Series C capital to rapidly expand internationally.
DCVC, which was a Seed and Series A lead and Series B investor, also materially participated in the round. With this new funding, Pivot Bio will accelerate its plans to scale its first-to-market microbial nitrogen technology that increases crop yields and farmer revenue. The technology also will aid in decreasing greenhouse gas emissions, water pollution, and global energy use related to the $65 billion global synthetic nitrogen fertilizer market. Pivot Bio PROVEN, the company’s inaugural product for corn, consistently delivers more nitrogen into the crop than synthetic nitrogen, translating to an average of 5.8 bushels per acre advantage when compared to fields using only synthetic nitrogen in 2019.
By adopting Pivot Bio’s cleaner nitrogen, agriculture aims to eliminate one gigaton of carbon dioxide–eq
